- Published at
- by gurufocus.com
neutral
neutral
Analyst Adjusts Tenax Therapeutics (TENX) Price Target, Maintains Buy Rating | TENX Stock News
An analyst from Guggenheim, Seamus Fernandez, has revised the price target for Tenax Therapeutics (TENX), reducing it from $16 to $15, while maintaining a Buy r